Vaccinex (VCNX) Competitors $0.75 +0.14 (+22.95%) As of 03/28/2025 03:17 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock VCNX vs. SNOA, NKGN, GTBP, SNGX, ALZN, AEZS, CANF, FRTX, NLSP, and CPHIShould you be buying Vaccinex stock or one of its competitors? The main competitors of Vaccinex include Sonoma Pharmaceuticals (SNOA), NKGen Biotech (NKGN), GT Biopharma (GTBP), Soligenix (SNGX), Alzamend Neuro (ALZN), Aeterna Zentaris (AEZS), Can-Fite BioPharma (CANF), Fresh Tracks Therapeutics (FRTX), NLS Pharmaceutics (NLSP), and China Pharma (CPHI). These companies are all part of the "pharmaceutical products" industry. Vaccinex vs. Sonoma Pharmaceuticals NKGen Biotech GT Biopharma Soligenix Alzamend Neuro Aeterna Zentaris Can-Fite BioPharma Fresh Tracks Therapeutics NLS Pharmaceutics China Pharma Vaccinex (NASDAQ:VCNX) and Sonoma Pharmaceuticals (NASDAQ:SNOA) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, earnings, institutional ownership, risk, dividends, media sentiment, valuation, profitability and community ranking. Which has more volatility and risk, VCNX or SNOA? Vaccinex has a beta of 1.1, meaning that its stock price is 10% more volatile than the S&P 500. Comparatively, Sonoma Pharmaceuticals has a beta of 1.56, meaning that its stock price is 56% more volatile than the S&P 500. Do institutionals & insiders hold more shares of VCNX or SNOA? 50.1% of Vaccinex shares are held by institutional investors. Comparatively, 2.0% of Sonoma Pharmaceuticals shares are held by institutional investors. 51.5% of Vaccinex shares are held by company insiders. Comparatively, 3.9% of Sonoma Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Is VCNX or SNOA more profitable? Vaccinex has a net margin of 0.00% compared to Sonoma Pharmaceuticals' net margin of -26.82%. Vaccinex's return on equity of 0.00% beat Sonoma Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets VaccinexN/A N/A -383.58% Sonoma Pharmaceuticals -26.82%-68.98%-26.39% Does the MarketBeat Community prefer VCNX or SNOA? Sonoma Pharmaceuticals received 93 more outperform votes than Vaccinex when rated by MarketBeat users. Likewise, 67.50% of users gave Sonoma Pharmaceuticals an outperform vote while only 60.00% of users gave Vaccinex an outperform vote. CompanyUnderperformOutperformVaccinexOutperform Votes12360.00% Underperform Votes8240.00% Sonoma PharmaceuticalsOutperform Votes21667.50% Underperform Votes10432.50% Which has better earnings & valuation, VCNX or SNOA? Sonoma Pharmaceuticals has higher revenue and earnings than Vaccinex. Sonoma Pharmaceuticals is trading at a lower price-to-earnings ratio than Vaccinex, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVaccinex$388K5.03-$20.25M-$48.27-0.02Sonoma Pharmaceuticals$13.97M0.28-$4.84M-$4.02-0.60 Does the media favor VCNX or SNOA? In the previous week, Sonoma Pharmaceuticals had 4 more articles in the media than Vaccinex. MarketBeat recorded 4 mentions for Sonoma Pharmaceuticals and 0 mentions for Vaccinex. Sonoma Pharmaceuticals' average media sentiment score of 0.79 beat Vaccinex's score of 0.00 indicating that Sonoma Pharmaceuticals is being referred to more favorably in the news media. Company Overall Sentiment Vaccinex Neutral Sonoma Pharmaceuticals Positive SummarySonoma Pharmaceuticals beats Vaccinex on 9 of the 15 factors compared between the two stocks. Remove Ads Get Vaccinex News Delivered to You Automatically Sign up to receive the latest news and ratings for VCNX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VCNX vs. The Competition Export to ExcelMetricVaccinexPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.76M$6.90B$5.63B$7.84BDividend YieldN/A2.77%5.33%4.01%P/E Ratio-0.027.2623.5518.73Price / Sales5.03218.62388.2390.77Price / CashN/A65.6738.1734.64Price / Book-0.296.386.894.23Net Income-$20.25M$142.34M$3.20B$247.47M7 Day Performance31.49%-5.15%-3.06%-2.29%1 Month Performance-31.82%-7.55%1.51%-5.81%1 Year Performance-89.88%-11.06%9.37%-0.96% Vaccinex Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VCNXVaccinexN/A$0.75+23.0%N/A-89.9%$2.76M$388,000.00-0.0240Upcoming EarningsGap DownSNOASonoma Pharmaceuticals0.3704 of 5 stars$3.86+9.3%N/A+1,349.2%$6.24M$13.97M-0.96180Short Interest ↑News CoverageGap DownNKGNNKGen BiotechN/A$0.14-19.4%N/A-91.4%$6.15M$80,000.00-0.03N/AGap DownGTBPGT Biopharma3.4561 of 5 stars$2.40-6.3%$11.00+358.3%-45.8%$6.09MN/A-0.348Short Interest ↓News CoverageSNGXSoligenix1.5072 of 5 stars$2.36+2.6%N/A-77.0%$5.92M$840,000.00-0.3120Earnings ReportShort Interest ↓Analyst RevisionNews CoverageGap DownALZNAlzamend Neuro3.4493 of 5 stars$0.89+32.1%$20.00+2,134.9%-89.4%$5.90MN/A0.004Short Interest ↓News CoverageGap UpAEZSAeterna ZentarisN/A$3.29+5.8%N/A-65.3%$5.90M$2.37M-0.2220Gap DownHigh Trading VolumeCANFCan-Fite BioPharma2.1645 of 5 stars$1.65+1.2%$14.00+748.5%-33.4%$5.84M$667,000.00-0.928Gap UpFRTXFresh Tracks TherapeuticsN/A$0.94-0.5%N/A+3.4%$5.59M$10.06M-0.6620NLSPNLS PharmaceuticsN/A$1.55-1.9%N/A+622.2%$5.58MN/A0.006Short Interest ↓CPHIChina PharmaN/A$0.29+18.3%N/A-26.0%$5.57M$5.54M0.00250Analyst ForecastNews CoverageGap UpHigh Trading Volume Remove Ads Related Companies and Tools Related Companies SNOA Competitors NKGN Competitors GTBP Competitors SNGX Competitors ALZN Competitors AEZS Competitors CANF Competitors FRTX Competitors NLSP Competitors CPHI Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:VCNX) was last updated on 3/30/2025 by MarketBeat.com Staff From Our PartnersNew Pick (93% history of rising by May 8)We just posted a new recommendation. Keep in mind: You could have boosted the Netflix trade we issued to the p...InvestorPlace | SponsoredTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...Paradigm Press | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredPartner with Elon Musk on Project Colossus… Before May 1stEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredHuge Elon-backed AI rollout begins – buy these nine stocksIf you suspect Elon Musk has an ulterior motive for coming to Washington, D.C.... You're 100% correct. ...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vaccinex, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vaccinex With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy VCNX Stock Free VCNX Stock Alerts